Acorda Therapeutics, Inc. Annual Return On Equity in % from 2017 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Acorda Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2017 to 2023.
  • Acorda Therapeutics, Inc. Return On Equity for the quarter ending March 31, 2024 was 486 %.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2023 was -2.21K %, a 3121% decline from 2022.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2022 was -68.5 %, a 17.4% decline from 2021.
  • Acorda Therapeutics, Inc. annual Return On Equity for 2021 was -58.4 %, a 68.4% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -2.21K -2.14K -3121% Jan 1, 2023 Dec 31, 2023
2022 -68.5 -10.1 -17.4% Jan 1, 2022 Dec 31, 2022
2021 -58.4 -23.7 -68.4% Jan 1, 2021 Dec 31, 2021
2020 -34.7 +29.4 +45.9% Jan 1, 2020 Dec 31, 2020
2019 -64.1 -69.8 -1226% Jan 1, 2019 Dec 31, 2019
2018 5.69 +40.5 Jan 1, 2018 Dec 31, 2018
2017 -34.8 Jan 1, 2017 Dec 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.